Company intelligence / Profile preview

Rhytec

Waltham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Rhytec was a medical technology company that developed and commercialized the Portrait Plasma Skin Regeneration (PSR) system. The technology used nitrogen plasma to deliver thermal energy to the skin, stimulating collagen production and treating various dermatological conditions such as wrinkles and actinic keratosis. Unlike traditional lasers, the Portrait system was non-ablative, leaving the outer layer of skin intact as a natural dressing during the healing process. The company was acquired by Gyrus Group in 2008, which was subsequently acquired by Olympus Corporation.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Rhytec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhytec.

Explore the full profile